Morphine Interaction with Aspirin: a Double-Blind, Crossover Trial in Healthy Volunteers
Aspirin is a cornerstone in the antiplatelet therapy for acute coronary syndromes. Coadministration of morphine may potentially influence the intestinal absorption, pharmacokinetics, and pharmacodynamics, as seen with P2Y12 inhibitors. In this trial, healthy volunteers were randomized to receive mor...
Saved in:
| Published in | The Journal of pharmacology and experimental therapeutics Vol. 365; no. 2; pp. 430 - 436 |
|---|---|
| Main Authors | , , , , , , |
| Format | Journal Article |
| Language | English |
| Published |
United States
Elsevier Inc
01.05.2018
|
| Subjects | |
| Online Access | Get full text |
Cover
Loading…
| Abstract | Aspirin is a cornerstone in the antiplatelet therapy for acute coronary syndromes. Coadministration of morphine may potentially influence the intestinal absorption, pharmacokinetics, and pharmacodynamics, as seen with P2Y12 inhibitors. In this trial, healthy volunteers were randomized to receive morphine (5 mg, i.v. bolus injection) at one of seven different time points before, after, or with aspirin (162 mg, p.o.) in a double-blind, placebo-controlled fashion. After a 14-day washout, subjects received placebo instead of morphine. Pharmacokinetics were determined by liquid chromatography, and aspirin’s effects were measured by platelet function tests (whole-blood platelet aggregation: multiplate, platelet plug formation: PFA-100). Morphine increased the total acetylsalicylic acid exposure by 20% compared with placebo when given simultaneously with aspirin, whereas Cmax and tmax were not altered. Morphine had no significant effect on aspirin-induced platelet inhibition. In contrast to coadministration with P2Y12 inhibitors, morphine appears to have negligible interaction with aspirin. |
|---|---|
| AbstractList | Aspirin is a cornerstone in the antiplatelet therapy for acute coronary syndromes. Coadministration of morphine may potentially influence the intestinal absorption, pharmacokinetics, and pharmacodynamics, as seen with P2Y12 inhibitors. In this trial, healthy volunteers were randomized to receive morphine (5 mg, i.v. bolus injection) at one of seven different time points before, after, or with aspirin (162 mg, p.o.) in a double-blind, placebo-controlled fashion. After a 14-day washout, subjects received placebo instead of morphine. Pharmacokinetics were determined by liquid chromatography, and aspirin's effects were measured by platelet function tests (whole-blood platelet aggregation: multiplate, platelet plug formation: PFA-100). Morphine increased the total acetylsalicylic acid exposure by 20% compared with placebo when given simultaneously with aspirin, whereas Cmax and tmax were not altered. Morphine had no significant effect on aspirin-induced platelet inhibition. In contrast to coadministration with P2Y12 inhibitors, morphine appears to have negligible interaction with aspirin.Aspirin is a cornerstone in the antiplatelet therapy for acute coronary syndromes. Coadministration of morphine may potentially influence the intestinal absorption, pharmacokinetics, and pharmacodynamics, as seen with P2Y12 inhibitors. In this trial, healthy volunteers were randomized to receive morphine (5 mg, i.v. bolus injection) at one of seven different time points before, after, or with aspirin (162 mg, p.o.) in a double-blind, placebo-controlled fashion. After a 14-day washout, subjects received placebo instead of morphine. Pharmacokinetics were determined by liquid chromatography, and aspirin's effects were measured by platelet function tests (whole-blood platelet aggregation: multiplate, platelet plug formation: PFA-100). Morphine increased the total acetylsalicylic acid exposure by 20% compared with placebo when given simultaneously with aspirin, whereas Cmax and tmax were not altered. Morphine had no significant effect on aspirin-induced platelet inhibition. In contrast to coadministration with P2Y12 inhibitors, morphine appears to have negligible interaction with aspirin. Aspirin is a cornerstone in the antiplatelet therapy for acute coronary syndromes. Coadministration of morphine may potentially influence the intestinal absorption, pharmacokinetics, and pharmacodynamics, as seen with P2Y inhibitors. In this trial, healthy volunteers were randomized to receive morphine (5 mg, i.v. bolus injection) at one of seven different time points before, after, or with aspirin (162 mg, p.o.) in a double-blind, placebo-controlled fashion. After a 14-day washout, subjects received placebo instead of morphine. Pharmacokinetics were determined by liquid chromatography, and aspirin's effects were measured by platelet function tests (whole-blood platelet aggregation: multiplate, platelet plug formation: PFA-100). Morphine increased the total acetylsalicylic acid exposure by 20% compared with placebo when given simultaneously with aspirin, whereas and were not altered. Morphine had no significant effect on aspirin-induced platelet inhibition. In contrast to coadministration with P2Y inhibitors, morphine appears to have negligible interaction with aspirin. Aspirin is a cornerstone in the antiplatelet therapy for acute coronary syndromes. Coadministration of morphine may potentially influence the intestinal absorption, pharmacokinetics, and pharmacodynamics, as seen with P2Y12 inhibitors. In this trial, healthy volunteers were randomized to receive morphine (5 mg, i.v. bolus injection) at one of seven different time points before, after, or with aspirin (162 mg, p.o.) in a double-blind, placebo-controlled fashion. After a 14-day washout, subjects received placebo instead of morphine. Pharmacokinetics were determined by liquid chromatography, and aspirin’s effects were measured by platelet function tests (whole-blood platelet aggregation: multiplate, platelet plug formation: PFA-100). Morphine increased the total acetylsalicylic acid exposure by 20% compared with placebo when given simultaneously with aspirin, whereas Cmax and tmax were not altered. Morphine had no significant effect on aspirin-induced platelet inhibition. In contrast to coadministration with P2Y12 inhibitors, morphine appears to have negligible interaction with aspirin. |
| Author | Hobl, Eva-Luise Schoergenhofer, Christian Schwameis, Michael Wadowski, Patricia Jilma, Bernd Bartko, Johann Kubica, Jacek |
| Author_xml | – sequence: 1 givenname: Johann surname: Bartko fullname: Bartko, Johann – sequence: 2 givenname: Christian surname: Schoergenhofer fullname: Schoergenhofer, Christian – sequence: 3 givenname: Michael surname: Schwameis fullname: Schwameis, Michael – sequence: 4 givenname: Patricia surname: Wadowski fullname: Wadowski, Patricia – sequence: 5 givenname: Jacek surname: Kubica fullname: Kubica, Jacek – sequence: 6 givenname: Bernd surname: Jilma fullname: Jilma, Bernd email: bernd.jilma@meduniwien.ac.at – sequence: 7 givenname: Eva-Luise surname: Hobl fullname: Hobl, Eva-Luise |
| BackLink | https://www.ncbi.nlm.nih.gov/pubmed/29540563$$D View this record in MEDLINE/PubMed |
| BookMark | eNp1kD1vFDEQhi2UiFwCNR1yScEm_t5dunB8JFIQTUB0ls-e1Tny2YvtDcq_x6dLmkjRFDPF-7zSPKfoKKYICL2j5JxSJi7uZqjt6s-Z6Bnlr9CKSkY7Qgk_QitCGOu4VPIEnZZyRwgVQvHX6ISNUhCp-Ar9-ZHyvPUR8HWskI2tPkX8z9ctviyzzz5-wgZ_ScsmQPc5-Og-4nVOpaR7yPg2exOwj_gKTKjbB_w7haX1QC5v0PFkQoG3j_sM_fr29XZ91d38_H69vrzpLGcj75QyivNeiVGZYRjURhlwVkjRi0n2oJhygoAZ3EZyJkFJGKbROWGmUZJx6vkZ-nDonXP6u0CpeueLhRBMhLQUzdrTbdQoWvT9Y3TZ7MDpOfudyQ_6yUYLyEPA7j_MMGnrq9kbqdn4oCnRe-t6b71dvT5Yb9zFM-6p-mViPBDQ1Nx7yLpYD9GC8xls1S75F9n_8BmXMg |
| CitedBy_id | crossref_primary_10_1136_bmjopen_2020_043330 crossref_primary_10_1016_j_rpth_2023_100138 crossref_primary_10_1080_17512433_2022_2121702 crossref_primary_10_17116_neiro202387061100 crossref_primary_10_1016_j_peptides_2020_170348 crossref_primary_10_3390_biomedicines11082284 crossref_primary_10_1007_s40262_023_01243_5 crossref_primary_10_1016_j_pharmthera_2020_107665 |
| Cites_doi | 10.1016/j.ahj.2016.04.004 10.1093/ehjcvp/pvx017 10.1111/j.1365-2125.1975.tb00568.x 10.1016/0002-9149(92)91316-V 10.1097/CCM.0b013e3181de8b1e 10.1016/j.ahj.2005.02.010 10.1177/009127009803801105 10.1007/s00392-015-0927-z 10.1016/j.jacc.2013.10.068 10.1093/eurheartj/ehv717 10.1172/JCI108132 10.1161/CIR.0000000000000456 10.1016/S0022-3565(25)11886-7 10.1056/NEJMoa1407024 10.1056/NEJMoa010746 10.1111/j.1365-2044.1994.tb03376.x 10.1001/jama.1965.03080020052015 10.1161/circoutcomes.10.suppl_3.083 10.1177/2048872615584078 10.2165/00003495-200363070-00003 10.2165/00003088-199528060-00001 10.1161/CIR.0b013e3182742c84 10.1007/s00392-015-0835-2 10.1093/eurheartj/ehv547 10.1111/bcp.13053 10.1042/cs0840517 10.1111/eci.12550 10.1056/NEJMoa1300815 10.1002/bmc.2846 10.1016/S0002-9149(99)00324-0 10.1160/TH10-08-0530 10.1161/CIRCULATIONAHA.117.031678 10.1016/j.ijcard.2016.04.077 |
| ContentType | Journal Article |
| Copyright | 2018 American Society for Pharmacology and Experimental Therapeutics Copyright © 2018 by The Author(s). |
| Copyright_xml | – notice: 2018 American Society for Pharmacology and Experimental Therapeutics – notice: Copyright © 2018 by The Author(s). |
| DBID | AAYXX CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| DOI | 10.1124/jpet.117.247213 |
| DatabaseName | CrossRef Medline MEDLINE MEDLINE (Ovid) MEDLINE MEDLINE PubMed MEDLINE - Academic |
| DatabaseTitle | CrossRef MEDLINE Medline Complete MEDLINE with Full Text PubMed MEDLINE (Ovid) MEDLINE - Academic |
| DatabaseTitleList | MEDLINE - Academic MEDLINE |
| Database_xml | – sequence: 1 dbid: NPM name: PubMed url: https://proxy.k.utb.cz/login?url=http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?db=PubMed sourceTypes: Index Database – sequence: 2 dbid: EIF name: MEDLINE url: https://proxy.k.utb.cz/login?url=https://www.webofscience.com/wos/medline/basic-search sourceTypes: Index Database |
| DeliveryMethod | fulltext_linktorsrc |
| Discipline | Pharmacy, Therapeutics, & Pharmacology |
| EISSN | 1521-0103 |
| EndPage | 436 |
| ExternalDocumentID | 29540563 10_1124_jpet_117_247213 S0022356524267550 |
| Genre | Clinical Trial Research Support, Non-U.S. Gov't Journal Article |
| GroupedDBID | --- -~X .55 .GJ 0R~ 18M 2WC 3O- 4.4 53G 5GY 5RE 5VS 8WZ A6W AAJMC AALRI AAXUO AAYOK ABCQX ABIVO ABJNI ABOCM ABSQV ACGFO ACGFS ACNCT ADBBV ADCOW ADIYS AENEX AERNN AFFNX AFHIN AFOSN AGFXO AI. ALMA_UNASSIGNED_HOLDINGS BAWUL BTFSW CS3 DIK DU5 E3Z EBS EJD F5P F9R FDB GX1 H13 HZ~ INIJC KQ8 L7B LSO M41 MJL MVM O9- OHT OK1 P2P PKN R.V R0Z RHF RHI ROL RPT TR2 UQL VH1 W2D W8F WH7 WOQ X7M YBU YHG YQT ZGI ZXP AAYXX ACVFH ADCNI AETEA AEUPX AFPUW AIGII AKBMS AKYEP CITATION CGR CUY CVF ECM EIF NPM 7X8 |
| ID | FETCH-LOGICAL-c3293-66a63376496a8886b6aedc45474f57e626d40ea8db5325e65e8f9dd4af9509f73 |
| ISSN | 0022-3565 1521-0103 |
| IngestDate | Fri Jul 11 16:33:02 EDT 2025 Sat Mar 08 01:25:24 EST 2025 Thu Apr 24 23:08:48 EDT 2025 Tue Jul 01 05:26:05 EDT 2025 Sat Feb 15 15:51:28 EST 2025 |
| IsDoiOpenAccess | false |
| IsOpenAccess | true |
| IsPeerReviewed | true |
| IsScholarly | true |
| Issue | 2 |
| Keywords | AA CT NSTE-ACS CEPI PD tmax MEA CEPI-CTs PK SA ASA AUC |
| Language | English |
| License | Copyright © 2018 by The Author(s). |
| LinkModel | OpenURL |
| MergedId | FETCHMERGED-LOGICAL-c3293-66a63376496a8886b6aedc45474f57e626d40ea8db5325e65e8f9dd4af9509f73 |
| Notes | ObjectType-Article-2 SourceType-Scholarly Journals-1 ObjectType-Feature-1 content type line 23 |
| OpenAccessLink | https://jpet.aspetjournals.org/content/jpet/365/2/430.full.pdf |
| PMID | 29540563 |
| PQID | 2014141694 |
| PQPubID | 23479 |
| PageCount | 7 |
| ParticipantIDs | proquest_miscellaneous_2014141694 pubmed_primary_29540563 crossref_citationtrail_10_1124_jpet_117_247213 crossref_primary_10_1124_jpet_117_247213 elsevier_sciencedirect_doi_10_1124_jpet_117_247213 |
| ProviderPackageCode | CITATION AAYXX |
| PublicationCentury | 2000 |
| PublicationDate | 2018-05-01 |
| PublicationDateYYYYMMDD | 2018-05-01 |
| PublicationDate_xml | – month: 05 year: 2018 text: 2018-05-01 day: 01 |
| PublicationDecade | 2010 |
| PublicationPlace | United States |
| PublicationPlace_xml | – name: United States |
| PublicationTitle | The Journal of pharmacology and experimental therapeutics |
| PublicationTitleAlternate | J Pharmacol Exp Ther |
| PublicationYear | 2018 |
| Publisher | Elsevier Inc |
| Publisher_xml | – name: Elsevier Inc |
| References | Lichtenberger, Phan, Fang, Edler, Philip, Li-Geng, Dial (bib21) 2016; 67 Bruce, Bing (bib6) 1965; 191 Kubica, Adamski, Ostrowska, Sikora, Kubica, Sroka, Stankowska, Buszko, Navarese, Jilma (bib18) 2016; 37 Bochner, Lloyd (bib4) 1995; 28 Chaudhuri (bib7) 1974; 15 Hobl, Stimpfl, Ebner, Schoergenhofer, Derhaschnig, Sunder-Plassmann, Jilma-Stohlawetz, Mannhalter, Posch, Jilma (bib14) 2014; 63 Sibbing, Kastrati, Berger (bib33) 2016; 37 Nimmo, Heading, Wilson, Tothill, Prescott (bib28) 1975; 2 Siller-Matula, Specht, Kubica, Alexopoulos, De Caterina, Hobl, Jilma, Christ, Lang (bib34) 2016; 82 Jakl, Sevcik, Fatorova, Horacek, Pudil (bib16) 2017; 17 Yuan, Foss, O’Connor, Roizen, Moss (bib37) 1998; 38 McCarthy CP, Bhambhani V, Pomerantsev E, Wasfy JH (2017) In-hospital outcomes in invasively managed acute myocardial infarction patients who receive morphine. Spiel, Bartko, Schwameis, Firbas, Siller-Matula, Schuetz, Weigl, Jilma (bib35) 2011; 105 Hobl, Reiter, Schoergenhofer, Schwameis, Derhaschnig, Kubica, Stimpfl, Jilma (bib12) 2016; 46 McEvoy, Ibrahim, Kickler, Clarke, Hasan, Czarny, Keramati, Goli, Gratton, Brinker (bib24) 2018; 137 Hobl, Jilma, Ebner, Schmid (bib11) 2013; 27 McCarthy, Mullins, Sidhu, Schulman, McEvoy (bib23) 2016; 176 DOI Wiggins, Saseen, Page, Reed, Sneed, Kostis, Lanfear, Virani, Morris (bib36) 2016; 134 Böger, Bode-Böger, Gutzki, Tsikas, Weskott, Frölich (bib5) 1993; 84 de Waha, Eitel, Desch, Fuernau, Lurz, Urban, Schuler, Thiele (bib8) 2015; 104 Kubica, Kubica, Jilma, Adamski, Hobl, Navarese, Siller-Matula, Dąbrowska, Fabiszak, Koziński (bib19) 2016; 215 Kurz, Sessler (bib20) 2003; 63 [published ahead of print]. Bhatt, Stone, Mahaffey, Gibson, Steg, Hamm, Price, Leonardi, Gallup, Bramucci (bib3) 2013; 368 O’Gara, Kushner, Ascheim, Casey, Chung, de Lemos, Ettinger, Fang, Fesmire, Franklin (bib29) 2013; 127 Yusuf, Zhao, Mehta, Chrolavicius, Tognoni, Fox (bib38) 2001; 345 Meine, Roe, Chen, Patel, Washam, Ohman, Peacock, Pollack, Gibler, Peterson (bib25) 2005; 149 Hogben, Schanker, Tocco, Brodie (bib15) 1957; 120 Mollace, Rosano, Malara, Di Fabrizio, Vitale, Coluccio, Maiuolo, Ali Wasti, Muscoli, Gliozzi (bib26) 2017; 3 Hobl, Reiter, Schoergenhofer, Schwameis, Derhaschnig, Lang, Stimpfl, Jilma (bib13) 2016; 105 Montalescot, van ’t Hof, Lapostolle, Silvain, Lassen, Bolognese, Cantor, Cequier, Chettibi, Goodman (bib27) 2014; 371 Feldman, Cryer (bib9) 1999; 84 Roth, Majerus (bib31) 1975; 56 Schrör (bib32) 2016 Jimenez, Stubbs, Tofler, Winther, Williams, Muller (bib17) 1992; 69 Parodi (bib30) 2016; 5 Bennett, Shah, Bembridge (bib2) 1994; 49 Fuchs, Spiel, Frossard, Derhaschnig, Riedmüller, Jilma (bib10) 2010; 38 Amsterdam, Wenger, Brindis, Casey, Ganiats, Holmes, Jaffe, Jneid, Kelly, Kontos (bib1) 2014; 130 McEvoy (10.1124/jpet.117.247213_bib24) 2018; 137 Schrör (10.1124/jpet.117.247213_bib32) 2016 Feldman (10.1124/jpet.117.247213_bib9) 1999; 84 Jakl (10.1124/jpet.117.247213_bib16) 2017; 17 Hobl (10.1124/jpet.117.247213_bib12) 2016; 46 Bennett (10.1124/jpet.117.247213_bib2) 1994; 49 Sibbing (10.1124/jpet.117.247213_bib33) 2016; 37 Böger (10.1124/jpet.117.247213_bib5) 1993; 84 Siller-Matula (10.1124/jpet.117.247213_bib34) 2016; 82 Kubica (10.1124/jpet.117.247213_bib18) 2016; 37 Hobl (10.1124/jpet.117.247213_bib11) 2013; 27 Hobl (10.1124/jpet.117.247213_bib14) 2014; 63 Jimenez (10.1124/jpet.117.247213_bib17) 1992; 69 Yuan (10.1124/jpet.117.247213_bib37) 1998; 38 O’Gara (10.1124/jpet.117.247213_bib29) 2013; 127 Hobl (10.1124/jpet.117.247213_bib13) 2016; 105 Spiel (10.1124/jpet.117.247213_bib35) 2011; 105 Fuchs (10.1124/jpet.117.247213_bib10) 2010; 38 Hogben (10.1124/jpet.117.247213_bib15) 1957; 120 Bhatt (10.1124/jpet.117.247213_bib3) 2013; 368 Kubica (10.1124/jpet.117.247213_bib19) 2016; 215 10.1124/jpet.117.247213_bib22 Nimmo (10.1124/jpet.117.247213_bib28) 1975; 2 Meine (10.1124/jpet.117.247213_bib25) 2005; 149 Mollace (10.1124/jpet.117.247213_bib26) 2017; 3 Chaudhuri (10.1124/jpet.117.247213_bib7) 1974; 15 de Waha (10.1124/jpet.117.247213_bib8) 2015; 104 Montalescot (10.1124/jpet.117.247213_bib27) 2014; 371 Lichtenberger (10.1124/jpet.117.247213_bib21) 2016; 67 Parodi (10.1124/jpet.117.247213_bib30) 2016; 5 Amsterdam (10.1124/jpet.117.247213_bib1) 2014; 130 Wiggins (10.1124/jpet.117.247213_bib36) 2016; 134 Yusuf (10.1124/jpet.117.247213_bib38) 2001; 345 Bochner (10.1124/jpet.117.247213_bib4) 1995; 28 Bruce (10.1124/jpet.117.247213_bib6) 1965; 191 Roth (10.1124/jpet.117.247213_bib31) 1975; 56 Kurz (10.1124/jpet.117.247213_bib20) 2003; 63 McCarthy (10.1124/jpet.117.247213_bib23) 2016; 176 |
| References_xml | – volume: 371 start-page: 1016 year: 2014 end-page: 1027 ident: bib27 article-title: Prehospital ticagrelor in ST-segment elevation myocardial infarction publication-title: N Engl J Med – volume: 105 start-page: 655 year: 2011 end-page: 662 ident: bib35 article-title: Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration: a randomised controlled trial publication-title: Thromb Haemost – volume: 69 start-page: 258 year: 1992 end-page: 262 ident: bib17 article-title: Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men publication-title: Am J Cardiol – volume: 3 start-page: 185 year: 2017 end-page: 188 ident: bib26 article-title: Aspirin wears smart publication-title: Eur Heart J Cardiovasc Pharmacother – volume: 63 start-page: 630 year: 2014 end-page: 635 ident: bib14 article-title: Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial publication-title: J Am Coll Cardiol – volume: 5 start-page: 277 year: 2016 end-page: 281 ident: bib30 article-title: Editor’s choice-chest pain relief in patients with acute myocardial infarction publication-title: Eur Heart J Acute Cardiovasc Care – volume: 176 start-page: 114 year: 2016 end-page: 121 ident: bib23 article-title: The on- and off-target effects of morphine in acute coronary syndrome: a narrative review publication-title: Am Heart J – volume: 37 start-page: 245 year: 2016 end-page: 252 ident: bib18 article-title: Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial publication-title: Eur Heart J – volume: 345 start-page: 494 year: 2001 end-page: 502 ident: bib38 article-title: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. [published correction appears in publication-title: N Engl J Med – volume: 38 start-page: 1017 year: 1998 end-page: 1020 ident: bib37 article-title: Effects of low-dose morphine on gastric emptying in healthy volunteers publication-title: J Clin Pharmacol – volume: 2 start-page: 509 year: 1975 end-page: 513 ident: bib28 article-title: Inhibition of gastric emptying and drug absorption by narcotic analgesics publication-title: Br J Clin Pharmacol – volume: 28 start-page: 433 year: 1995 end-page: 438 ident: bib4 article-title: Aspirin for myocardial infarction. Clinical pharmacokinetic considerations publication-title: Clin Pharmacokinet – volume: 191 start-page: 124 year: 1965 end-page: 126 ident: bib6 article-title: Clinical management of myocardial infarction publication-title: JAMA – volume: 127 start-page: e362 year: 2013 end-page: e425 ident: bib29 article-title: 2013 ACCF/AHA guideline for the management of ST-elevation myocardial infarction: a report of the American College of Cardiology Foundation/American Heart Association task force on practice guidelines [published correction appears in publication-title: Circulation – volume: 46 start-page: 7 year: 2016 end-page: 14 ident: bib12 article-title: Morphine decreases ticagrelor concentrations but not its antiplatelet effects: a randomized trial in healthy volunteers publication-title: Eur J Clin Invest – volume: 49 start-page: 155 year: 1994 end-page: 156 ident: bib2 article-title: A comparison of the effect on gastric emptying of alfentanil or morphine given during anaesthesia for minor surgery publication-title: Anaesthesia – volume: 104 start-page: 727 year: 2015 end-page: 734 ident: bib8 article-title: Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging publication-title: Clin Res Cardiol – volume: 215 start-page: 201 year: 2016 end-page: 208 ident: bib19 article-title: Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors publication-title: Int J Cardiol – volume: 105 start-page: 349 year: 2016 end-page: 355 ident: bib13 article-title: Morphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteers publication-title: Clin Res Cardiol – volume: 37 start-page: 1284 year: 2016 end-page: 1295 ident: bib33 article-title: Pre-treatment with P2Y12 inhibitors in ACS patients: who, when, why, and which agent? publication-title: Eur Heart J – year: 2016 ident: bib32 article-title: Acetylsalicylic Acid – volume: 15 start-page: 391 year: 1974 end-page: 395 ident: bib7 article-title: Use of 99mTc-DTPA for measuring gastric emptying time publication-title: J Nucl Med – volume: 134 start-page: e468 year: 2016 end-page: e495 ident: bib36 article-title: Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association publication-title: Circulation – volume: 56 start-page: 624 year: 1975 end-page: 632 ident: bib31 article-title: The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein publication-title: J Clin Invest – volume: 63 start-page: 649 year: 2003 end-page: 671 ident: bib20 article-title: Opioid-induced bowel dysfunction: pathophysiology and potential new therapies publication-title: Drugs – volume: 38 start-page: 1423 year: 2010 end-page: 1429 ident: bib10 article-title: Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy publication-title: Crit Care Med – reference: [published ahead of print]. – volume: 17 start-page: 113 year: 2017 end-page: 118 ident: bib16 article-title: High on-treatment platelet reactivity: risk factors and 5-year outcomes in patients with acute myocardial infarction publication-title: Anatol J Cardiol – volume: 368 start-page: 1303 year: 2013 end-page: 1313 ident: bib3 article-title: Effect of platelet inhibition with cangrelor during PCI on ischemic events publication-title: N Engl J Med – reference: McCarthy CP, Bhambhani V, Pomerantsev E, Wasfy JH (2017) In-hospital outcomes in invasively managed acute myocardial infarction patients who receive morphine. – volume: 137 start-page: 307 year: 2018 end-page: 309 ident: bib24 article-title: Effect of intravenous fentanyl on ticagrelor absorption and platelet inhibition among patients undergoing percutaneous coronary intervention: the PACIFY randomized clinical trial (platelet aggregation with ticagrelor inhibition and fentanyl) publication-title: Circulation – volume: 84 start-page: 404 year: 1999 end-page: 409 ident: bib9 article-title: Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution publication-title: Am J Cardiol – reference: DOI: – volume: 149 start-page: 1043 year: 2005 end-page: 1049 ident: bib25 article-title: Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE quality improvement initiative publication-title: Am Heart J – volume: 82 start-page: 1343 year: 2016 end-page: 1350 ident: bib34 article-title: Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients publication-title: Br J Clin Pharmacol – volume: 84 start-page: 517 year: 1993 end-page: 524 ident: bib5 article-title: Rapid and selective inhibition of platelet aggregation and thromboxane formation by intravenous low dose aspirin in man publication-title: Clin Sci (Lond) – volume: 67 start-page: 635 year: 2016 end-page: 642 ident: bib21 article-title: Bioavailability of aspirin in rats comparing the drug’s uptake into gastrointestinal tissue and vascular and lymphatic systems: implications on aspirin’s chemopreventive action publication-title: J Physiol Pharmacol – volume: 120 start-page: 540 year: 1957 end-page: 545 ident: bib15 article-title: Absorption of drugs from the stomach. II. The human publication-title: J Pharmacol Exp Ther – volume: 27 start-page: 695 year: 2013 end-page: 698 ident: bib11 article-title: Simultaneous determination of acetylsalicylic acid and salicylic acid in human plasma by isocratic high-pressure liquid chromatography with post-column hydrolysis and fluorescence detection publication-title: Biomed Chromatogr – volume: 130 start-page: e344 year: 2014 end-page: e426 ident: bib1 article-title: 2014 AHA/ACC guideline for the management of patients with non-ST-elevation acute coronary syndromes: a report of the American College of Cardiology/American Heart Association Task Force on practice guidelines [published correction appears in publication-title: Circulation – volume: 130 start-page: e344 year: 2014 ident: 10.1124/jpet.117.247213_bib1 publication-title: Circulation – volume: 176 start-page: 114 year: 2016 ident: 10.1124/jpet.117.247213_bib23 article-title: The on- and off-target effects of morphine in acute coronary syndrome: a narrative review publication-title: Am Heart J doi: 10.1016/j.ahj.2016.04.004 – volume: 3 start-page: 185 year: 2017 ident: 10.1124/jpet.117.247213_bib26 article-title: Aspirin wears smart publication-title: Eur Heart J Cardiovasc Pharmacother doi: 10.1093/ehjcvp/pvx017 – volume: 2 start-page: 509 year: 1975 ident: 10.1124/jpet.117.247213_bib28 article-title: Inhibition of gastric emptying and drug absorption by narcotic analgesics publication-title: Br J Clin Pharmacol doi: 10.1111/j.1365-2125.1975.tb00568.x – volume: 69 start-page: 258 year: 1992 ident: 10.1124/jpet.117.247213_bib17 article-title: Rapidity and duration of platelet suppression by enteric-coated aspirin in healthy young men publication-title: Am J Cardiol doi: 10.1016/0002-9149(92)91316-V – volume: 67 start-page: 635 year: 2016 ident: 10.1124/jpet.117.247213_bib21 article-title: Bioavailability of aspirin in rats comparing the drug’s uptake into gastrointestinal tissue and vascular and lymphatic systems: implications on aspirin’s chemopreventive action publication-title: J Physiol Pharmacol – volume: 38 start-page: 1423 year: 2010 ident: 10.1124/jpet.117.247213_bib10 article-title: Platelet hyperfunction is decreased by additional aspirin loading in patients presenting with myocardial infarction on daily aspirin therapy publication-title: Crit Care Med doi: 10.1097/CCM.0b013e3181de8b1e – volume: 149 start-page: 1043 year: 2005 ident: 10.1124/jpet.117.247213_bib25 article-title: Association of intravenous morphine use and outcomes in acute coronary syndromes: results from the CRUSADE quality improvement initiative publication-title: Am Heart J doi: 10.1016/j.ahj.2005.02.010 – volume: 38 start-page: 1017 year: 1998 ident: 10.1124/jpet.117.247213_bib37 article-title: Effects of low-dose morphine on gastric emptying in healthy volunteers publication-title: J Clin Pharmacol doi: 10.1177/009127009803801105 – volume: 105 start-page: 349 year: 2016 ident: 10.1124/jpet.117.247213_bib13 article-title: Morphine interaction with prasugrel: a double-blind, cross-over trial in healthy volunteers publication-title: Clin Res Cardiol doi: 10.1007/s00392-015-0927-z – volume: 63 start-page: 630 year: 2014 ident: 10.1124/jpet.117.247213_bib14 article-title: Morphine decreases clopidogrel concentrations and effects: a randomized, double-blind, placebo-controlled trial publication-title: J Am Coll Cardiol doi: 10.1016/j.jacc.2013.10.068 – volume: 17 start-page: 113 year: 2017 ident: 10.1124/jpet.117.247213_bib16 article-title: High on-treatment platelet reactivity: risk factors and 5-year outcomes in patients with acute myocardial infarction publication-title: Anatol J Cardiol – volume: 37 start-page: 1284 year: 2016 ident: 10.1124/jpet.117.247213_bib33 article-title: Pre-treatment with P2Y12 inhibitors in ACS patients: who, when, why, and which agent? publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv717 – volume: 56 start-page: 624 year: 1975 ident: 10.1124/jpet.117.247213_bib31 article-title: The mechanism of the effect of aspirin on human platelets. I. Acetylation of a particulate fraction protein publication-title: J Clin Invest doi: 10.1172/JCI108132 – volume: 134 start-page: e468 year: 2016 ident: 10.1124/jpet.117.247213_bib36 article-title: Recommendations for management of clinically significant drug-drug interactions with statins and select agents used in patients with cardiovascular disease: a scientific statement from the American Heart Association publication-title: Circulation doi: 10.1161/CIR.0000000000000456 – volume: 120 start-page: 540 year: 1957 ident: 10.1124/jpet.117.247213_bib15 article-title: Absorption of drugs from the stomach. II. The human publication-title: J Pharmacol Exp Ther doi: 10.1016/S0022-3565(25)11886-7 – volume: 371 start-page: 1016 year: 2014 ident: 10.1124/jpet.117.247213_bib27 article-title: Prehospital ticagrelor in ST-segment elevation myocardial infarction publication-title: N Engl J Med doi: 10.1056/NEJMoa1407024 – volume: 345 start-page: 494 year: 2001 ident: 10.1124/jpet.117.247213_bib38 article-title: Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. [published correction appears in N Engl J Med (2001) 345:1716] publication-title: N Engl J Med doi: 10.1056/NEJMoa010746 – volume: 49 start-page: 155 year: 1994 ident: 10.1124/jpet.117.247213_bib2 article-title: A comparison of the effect on gastric emptying of alfentanil or morphine given during anaesthesia for minor surgery publication-title: Anaesthesia doi: 10.1111/j.1365-2044.1994.tb03376.x – volume: 191 start-page: 124 year: 1965 ident: 10.1124/jpet.117.247213_bib6 article-title: Clinical management of myocardial infarction publication-title: JAMA doi: 10.1001/jama.1965.03080020052015 – ident: 10.1124/jpet.117.247213_bib22 doi: 10.1161/circoutcomes.10.suppl_3.083 – volume: 15 start-page: 391 year: 1974 ident: 10.1124/jpet.117.247213_bib7 article-title: Use of 99mTc-DTPA for measuring gastric emptying time publication-title: J Nucl Med – volume: 5 start-page: 277 year: 2016 ident: 10.1124/jpet.117.247213_bib30 article-title: Editor’s choice-chest pain relief in patients with acute myocardial infarction publication-title: Eur Heart J Acute Cardiovasc Care doi: 10.1177/2048872615584078 – volume: 63 start-page: 649 year: 2003 ident: 10.1124/jpet.117.247213_bib20 article-title: Opioid-induced bowel dysfunction: pathophysiology and potential new therapies publication-title: Drugs doi: 10.2165/00003495-200363070-00003 – volume: 28 start-page: 433 year: 1995 ident: 10.1124/jpet.117.247213_bib4 article-title: Aspirin for myocardial infarction. Clinical pharmacokinetic considerations publication-title: Clin Pharmacokinet doi: 10.2165/00003088-199528060-00001 – volume: 127 start-page: e362 year: 2013 ident: 10.1124/jpet.117.247213_bib29 publication-title: Circulation doi: 10.1161/CIR.0b013e3182742c84 – volume: 104 start-page: 727 year: 2015 ident: 10.1124/jpet.117.247213_bib8 article-title: Intravenous morphine administration and reperfusion success in ST-elevation myocardial infarction: insights from cardiac magnetic resonance imaging publication-title: Clin Res Cardiol doi: 10.1007/s00392-015-0835-2 – volume: 37 start-page: 245 year: 2016 ident: 10.1124/jpet.117.247213_bib18 article-title: Morphine delays and attenuates ticagrelor exposure and action in patients with myocardial infarction: the randomized, double-blind, placebo-controlled IMPRESSION trial publication-title: Eur Heart J doi: 10.1093/eurheartj/ehv547 – volume: 82 start-page: 1343 year: 2016 ident: 10.1124/jpet.117.247213_bib34 article-title: Abciximab as a bridging strategy to overcome morphine-prasugrel interaction in STEMI patients publication-title: Br J Clin Pharmacol doi: 10.1111/bcp.13053 – volume: 84 start-page: 517 year: 1993 ident: 10.1124/jpet.117.247213_bib5 article-title: Rapid and selective inhibition of platelet aggregation and thromboxane formation by intravenous low dose aspirin in man publication-title: Clin Sci (Lond) doi: 10.1042/cs0840517 – volume: 46 start-page: 7 year: 2016 ident: 10.1124/jpet.117.247213_bib12 article-title: Morphine decreases ticagrelor concentrations but not its antiplatelet effects: a randomized trial in healthy volunteers publication-title: Eur J Clin Invest doi: 10.1111/eci.12550 – volume: 368 start-page: 1303 year: 2013 ident: 10.1124/jpet.117.247213_bib3 article-title: Effect of platelet inhibition with cangrelor during PCI on ischemic events publication-title: N Engl J Med doi: 10.1056/NEJMoa1300815 – volume: 27 start-page: 695 year: 2013 ident: 10.1124/jpet.117.247213_bib11 article-title: Simultaneous determination of acetylsalicylic acid and salicylic acid in human plasma by isocratic high-pressure liquid chromatography with post-column hydrolysis and fluorescence detection publication-title: Biomed Chromatogr doi: 10.1002/bmc.2846 – volume: 84 start-page: 404 year: 1999 ident: 10.1124/jpet.117.247213_bib9 article-title: Aspirin absorption rates and platelet inhibition times with 325-mg buffered aspirin tablets (chewed or swallowed intact) and with buffered aspirin solution publication-title: Am J Cardiol doi: 10.1016/S0002-9149(99)00324-0 – volume: 105 start-page: 655 year: 2011 ident: 10.1124/jpet.117.247213_bib35 article-title: Increased platelet aggregation and in vivo platelet activation after granulocyte colony-stimulating factor administration: a randomised controlled trial publication-title: Thromb Haemost doi: 10.1160/TH10-08-0530 – volume: 137 start-page: 307 year: 2018 ident: 10.1124/jpet.117.247213_bib24 article-title: Effect of intravenous fentanyl on ticagrelor absorption and platelet inhibition among patients undergoing percutaneous coronary intervention: the PACIFY randomized clinical trial (platelet aggregation with ticagrelor inhibition and fentanyl) publication-title: Circulation doi: 10.1161/CIRCULATIONAHA.117.031678 – year: 2016 ident: 10.1124/jpet.117.247213_bib32 – volume: 215 start-page: 201 year: 2016 ident: 10.1124/jpet.117.247213_bib19 article-title: Impact of morphine on antiplatelet effects of oral P2Y12 receptor inhibitors publication-title: Int J Cardiol doi: 10.1016/j.ijcard.2016.04.077 |
| SSID | ssj0014463 |
| Score | 2.3138945 |
| Snippet | Aspirin is a cornerstone in the antiplatelet therapy for acute coronary syndromes. Coadministration of morphine may potentially influence the intestinal... |
| SourceID | proquest pubmed crossref elsevier |
| SourceType | Aggregation Database Index Database Enrichment Source Publisher |
| StartPage | 430 |
| SubjectTerms | Adult Aspirin - pharmacokinetics Aspirin - pharmacology Cross-Over Studies Double-Blind Method Drug Interactions Female Healthy Volunteers Humans Male Morphine - pharmacology Tissue Distribution - drug effects |
| Title | Morphine Interaction with Aspirin: a Double-Blind, Crossover Trial in Healthy Volunteers |
| URI | https://dx.doi.org/10.1124/jpet.117.247213 https://www.ncbi.nlm.nih.gov/pubmed/29540563 https://www.proquest.com/docview/2014141694 |
| Volume | 365 |
| hasFullText | 1 |
| inHoldings | 1 |
| isFullTextHit | |
| isPrint | |
| link | http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwnV1bb9MwFLbKeOEFcafcZCQ0Ia0pne2kCW9j2jTBNoaUor5ZdmxrFSOZoNU0_gR_meNLEgOrNHiJoih2rXxfj8_xuSH0aqpSsy2ZTlSqqoQpwEJKKhPBjGDFpBDeXXB0nB3M2Pt5Oh8MfkZRS6ulHFc_rswr-R9U4RngarNk_wHZblJ4APeAL1wBYbheC-OjBr6SVRPduV7o-u1OVnesA31R-1RmUJLlmU7egUbp8Ny1O6MN3dwqfc-OOmQjXW59hvXCXCEsvtVa-_wxp7me9-WuffWm39oERBld_RE8LP5LE0J_Rd0R0tYAdemfp40JGYmnQepEr1yIr9qXQoiD_J0XQDUXofG27zWwEPExxnbeBw22kpfYc42Jl3b6imdBXFPfWyLwkkTCl3kPz9-bAmF2UwArxLqox4SB1Uv7_a_1-R9_5Puzw0Ne7s3LG-gmAbvDCs4Pn3q3FNjOLmOjXVeoFQU_8OaP6depOevMGKfOlHfQ7YAm3vGkuosGur6HNk88spcjXEYojvAmPokwv4_mLfNwxDxsmYcD895igWPejXDHOuxYhxc1DqzDPeseoNn-Xrl7kIQeHUlFQVNMskxkFDYpVmQiz_NMZkKrylaJYyadajCXFZtokSuZUpLqLNW5KZRiwhSgqpopfYg26qbWjxGmwigQDowaYhvATISgOZM0T1NtWKbJEI3bT8qrUMDe9lE5486QJYxbDGz1eu4xGKLX3YBzX7tl_aukxYgH1dOrlBxItH7QyxZNDkLZetpErZvVd05s-DSYOgUbokce5m4F1rEOVgd9co3RT9Gt_r_yDG0sv630c1CCl_KFI-YvmC-2IA |
| linkProvider | Colorado Alliance of Research Libraries |
| openUrl | ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Ajournal&rft.genre=article&rft.atitle=Morphine+Interaction+with+Aspirin%3A+a+Double-Blind%2C+Crossover+Trial+in+Healthy+Volunteers&rft.jtitle=The+Journal+of+pharmacology+and+experimental+therapeutics&rft.au=Bartko%2C+Johann&rft.au=Schoergenhofer%2C+Christian&rft.au=Schwameis%2C+Michael&rft.au=Wadowski%2C+Patricia&rft.date=2018-05-01&rft.issn=1521-0103&rft.eissn=1521-0103&rft.volume=365&rft.issue=2&rft.spage=430&rft_id=info:doi/10.1124%2Fjpet.117.247213&rft.externalDBID=NO_FULL_TEXT |
| thumbnail_l | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/lc.gif&issn=0022-3565&client=summon |
| thumbnail_m | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/mc.gif&issn=0022-3565&client=summon |
| thumbnail_s | http://covers-cdn.summon.serialssolutions.com/index.aspx?isbn=/sc.gif&issn=0022-3565&client=summon |